interferon
ifn
also
known
interleukin
il
belong
recent
discov
group
type
iii
ifn
type
iii
ifn
initi
signal
process
format
specif
heterodimer
receptor
complex
consist
determin
structur
human
complex
human
receptor
uniqu
type
iii
ifn
overal
structur
topolog
similar
structur
member
famili
cytokin
consist
two
distinct
domain
fibronectin
type
iii
topolog
ligandreceptor
interfac
includ
helix
loop
ab
helix
f
ifn
site
well
loop
primarili
ntermin
domain
interdomain
hing
region
composit
architectur
interfac
includ
direct
hydrogen
bond
support
idea
longrang
ionic
interact
ligand
receptor
govern
process
initi
recognit
molecul
hydrophob
interact
final
publish
elsevi
ltd
correspond
author
email
address
wlodaw
nihgov
deceas
paper
dedic
memori
dr
alexand
sasha
zdanov
lead
project
untim
death
miss
interferon
ifn
class
ii
cytokin
belong
recent
identifi
group
type
iii
ifn
cytokin
also
design
interleukin
il
respect
togeth
classic
type
ifn
serv
master
regul
multifacet
antivir
respons
antivir
activ
demonstr
broad
varieti
virus
cell
cultur
experi
vivo
exampl
shown
inhibit
infect
hepat
c
viru
hcv
hepat
b
viru
number
respiratori
virus
infect
epitheli
cell
influenza
b
respiratori
syncyti
viru
human
metapneumoviru
sever
acut
respiratori
syndrom
herp
simplex
viru
type
cytomegaloviru
cmv
type
type
iii
ifn
coproduc
variou
nucleat
cell
respons
live
viral
infect
varieti
stimuli
lipopolysaccharid
poli
c
bacterialvir
dna
trigger
tolllik
receptor
signal
moreov
type
ifn
activ
signal
transduct
pathway
includ
format
ifnstimul
gene
factor
transcript
complex
type
ifn
induc
express
set
gene
therefor
similar
biolog
activ
includ
strong
intrins
antivir
activ
howev
wherea
type
ifn
abl
activ
potent
antivir
state
wide
varieti
cell
type
iii
ifn
primarili
activ
epitheli
cell
celltyp
select
action
type
iii
ifn
possibl
type
ifn
engag
uniqu
receptor
complex
signal
distinct
express
pattern
ifn
receptor
type
ifn
signal
common
cellular
receptor
complex
compos
two
uniqu
subunit
ubiquit
express
howev
type
iii
ifn
signal
receptor
complex
consist
uniqu
chain
share
chain
latter
also
second
subunit
receptor
complex
contrast
ubiquit
express
receptor
subunit
chain
chain
express
primarili
epitheli
cell
dendrit
cell
restrict
action
type
iii
ifn
epitheli
cell
shown
low
affin
compon
receptor
complex
presum
low
affin
well
addit
wellknown
antivir
activ
demonstr
may
anticanc
activ
well
shown
reduc
prolifer
sever
cancer
cell
line
colorectalcancerderiv
cell
glioblastoma
cell
aneuroendocrin
tumor
cell
certain
esophag
cancer
cell
line
found
inhibit
growth
phase
arrest
enhanc
antitumor
effect
combin
anticanc
chemotherapeut
agent
proteasom
inhibitor
bortezomib
augment
antiprolif
proapoptot
effect
cancer
cell
use
murin
tumor
model
shown
inhibit
growth
fibrosarcoma
cell
vivo
retard
suppress
growth
melanoma
cell
bnl
hepatoma
cell
mice
studi
suggest
investig
could
benefit
treatment
viral
diseas
chronic
hepat
c
also
cancer
chemotherapeut
given
limit
express
throughout
bodi
also
like
use
treatment
option
would
gener
toler
better
treatment
ubiquit
recogn
ifn
three
known
type
iii
ifn
demonstr
limit
amino
acid
similar
type
ifn
cytokin
hand
level
amino
acid
conserv
high
among
member
famili
similar
yet
activ
differ
wherea
activ
knowledg
structur
detail
receptor
complex
may
provid
insight
differenti
activ
cytokin
known
ifn
il
receptor
subunit
includ
structur
relat
share
low
degre
amino
acid
similar
extracellular
domain
ident
rang
belong
famili
class
ii
cytokin
receptor
structur
sever
ifn
famili
member
well
dimer
trimer
cytokin
receptor
complex
elucid
crystallographi
nmr
structur
inform
avail
human
viral
latter
epsteinbarr
viru
ebv
cmv
well
complex
structur
determin
absenc
receptor
wherea
crystal
alon
complex
receptorligand
structur
includ
dimer
bind
ratio
ligandreceptor
interfac
consist
residu
resid
helix
loop
ab
helix
f
interdomain
loop
primarili
stabil
hydrophob
interact
suggest
base
structur
bound
receptorbind
site
share
ebv
bind
lower
affin
due
small
chang
ebv
posit
interhelix
loop
ebv
contrast
cmv
exhibit
affin
similar
differ
interdomain
angl
compar
model
bind
propos
recent
base
sitedirect
mutagenesi
experi
updat
previous
publish
model
ternari
complex
addit
model
bind
cmv
propos
crystal
structur
isol
determin
recent
shown
molecul
monom
highli
similar
one
domain
domainswap
molecul
despit
low
sequenc
homolog
two
protein
singlenucleotid
polymorph
snp
caus
amino
acid
substitut
within
type
iii
ifn
genom
locu
found
patient
spontan
clear
chronic
hcv
infect
well
patient
respond
well
treatment
hcv
infect
unknown
variat
affect
activ
variou
member
famili
follow
previou
report
protein
product
crystal
report
determin
analysi
xray
crystal
structur
express
escherichia
coli
drosophila
cell
complex
receptor
express
drosophila
cell
structur
show
complex
monomer
oppos
complex
seen
interfac
two
protein
highli
hydrophob
natur
amino
acid
composit
bond
pattern
suggest
electrostat
interact
may
respons
initi
ligandreceptor
associ
hydrophob
interact
solidifi
interact
overal
fold
similar
cytokin
cytokin
receptor
respect
complex
offer
hint
subtl
variat
might
influenc
activ
cytokin
toward
hcv
determin
crystal
structur
bound
highaffin
receptor
use
crystal
experi
express
e
coli
cell
bac
drosophila
cell
in
wherea
express
insect
cell
complex
form
molar
ratio
purifi
crystal
detail
express
purif
crystal
data
collect
procedur
previous
describ
crystal
structur
solv
use
molecular
replac
reveal
complex
consist
bound
ratio
sinc
two
structur
determin
work
essenti
ident
one
anoth
structur
in
complex
fig
structur
complex
green
cyan
glycosyl
site
blue
asn
yellow
carbohydr
glycerol
magenta
disulfid
bond
yellow
sphere
residu
interfac
orang
residu
interfac
red
amino
acid
side
chain
carbohydr
solvent
molecul
depict
stick
format
locat
site
site
interfac
label
b
structur
orient
found
helic
found
ligand
label
f
n
c
termini
also
label
c
structur
orient
found
loop
found
receptor
label
n
c
termini
label
well
disulfid
bond
depict
yellow
stick
discuss
part
in
complex
could
model
contain
residu
residu
addit
water
molecul
glycerol
molecul
nlink
glycosyl
site
also
model
model
possess
good
stereochemistri
evalu
molprob
residu
found
disallow
region
ramachandran
plot
in
refin
final
rfactor
r
work
r
free
respect
molecul
compos
six
helic
af
fig
helic
c
f
form
classic
upupdowndown
fourhelix
bundl
topolog
similar
member
famili
particularli
uniqu
featur
structur
compar
cytokin
mention
absenc
short
helix
visual
electron
densiti
preced
main
bodi
helix
similar
featur
found
structur
whose
amino
acid
sequenc
ident
spite
fact
differ
found
n
termini
protein
amino
residu
fig
unless
mention
otherwis
number
use
throughout
articl
differ
two
member
type
iii
ifn
famili
pattern
disulfid
bridg
five
cystein
present
possess
seven
cystein
disulfid
form
wherea
disord
free
disulfid
bridg
form
wherea
free
solut
make
intermolecular
disulfid
bridg
neighbor
molecul
crystal
number
although
use
make
in
crystal
produc
drosophila
cell
nlink
glycosyl
occur
evid
glycosyl
found
electron
densiti
observ
howev
proof
lack
glycosyl
like
result
influenc
crystalpack
contact
loop
ab
helix
symmetr
relat
molecul
prevent
put
glycosyl
visual
electron
densiti
crystallograph
symmetri
result
creation
dimer
dimer
bear
similar
true
dimer
seen
structur
like
due
lattic
pack
in
bac
complex
compar
restraint
impos
free
respect
crystalpack
environ
consequ
complex
form
ratio
oppos
ratio
dimer
found
complex
structur
structur
present
first
give
insight
ligand
recognit
bind
molecul
correspond
extracellular
portion
compos
two
domain
fig
domain
form
sandwich
two
sheet
sheet
compos
three
four
stand
domain
link
loop
short
helic
turn
middl
equival
conform
also
found
hematopoiet
cytokin
receptor
label
fibronectin
type
iii
domain
fibronectin
type
iii
domain
orient
domain
angl
one
anoth
ligand
bind
receptor
apex
two
domain
interdomain
angl
measur
use
c
carbon
posit
equival
residu
use
defin
interdomain
angl
interdomain
angl
smaller
report
anoth
exclam
point
sequenc
indic
locat
site
mutat
shown
impact
activ
ident
amino
acid
residu
shown
green
glycosyl
site
pink
signal
peptid
purpl
variat
red
cystein
yellow
purpl
indic
residu
visual
date
known
structur
blue
letter
sequenc
indic
locat
type
secondarystructur
element
found
b
indic
strand
h
indic
presenc
helix
indic
conserv
residu
indic
partial
conserv
residu
indic
presenc
similar
residu
disulfid
bridg
free
disulfid
bridg
free
loop
join
particip
interact
ligand
label
fig
contact
primarili
hydrophob
natur
see
import
featur
uniqu
present
cytokin
receptor
interdomain
disulfid
bridg
disulfid
found
cytokin
receptor
known
structur
except
far
disulfid
bridg
link
togeth
limit
possibl
interdomain
movement
restrict
certainli
affect
bind
specif
receptor
toward
ligand
howev
interdomain
orient
highli
similar
like
interdomain
restrict
impos
disulfid
imped
conform
chang
format
ternari
complex
contribut
prevent
ifn
il
signal
receptor
complex
presum
maintain
receptorligand
specif
glycosyl
site
present
side
chain
receptor
link
singl
visibl
nacetylglucosamin
nag
moieti
modifi
nagnagmannos
structur
bac
carbohydr
form
contact
symmetr
relat
molecul
help
build
crystal
lattic
supplement
fig
base
detail
ternari
complex
cmv
would
appear
glycosyl
site
posit
interfer
format
ternari
complex
complex
compos
one
molecul
bound
one
molecul
unlik
structur
cmv
complex
evid
disulfidelink
dimer
format
bind
occur
two
complementari
surfac
made
helix
loop
ab
helix
f
side
ligand
wherea
surfac
receptor
vicin
interdomain
area
includ
loop
domain
loop
domain
fig
none
oligosaccharid
involv
ligandreceptor
interact
amino
acid
residu
involv
interfac
surfac
fig
wherea
amino
acid
residu
side
interact
surfac
tightli
pack
hydrophob
larg
solvent
free
shape
complementar
sc
valu
sc
valu
bac
structur
sc
valu
similar
antibodyantigen
complex
suggest
strong
associ
interact
consist
larg
van
der
waal
hydrophob
contact
oppos
hydrogen
bond
purpos
discuss
interact
place
two
group
interact
helix
ligand
loop
receptor
site
interact
helix
f
ligand
loop
receptor
site
interact
buri
surfac
area
respect
site
helix
contain
sever
residu
make
hydrogen
bond
receptor
hydrogen
bond
made
ligand
receptor
ligand
receptor
ligand
receptor
respect
fig
mention
interfac
ligand
receptor
larg
solvent
free
howev
two
water
bridg
hydrogen
bond
ligand
receptor
ligand
receptor
rel
pauciti
direct
bond
compar
nonbond
contact
hydrogen
bond
versu
nonbond
contact
suggest
hydrogen
bond
respons
initi
recognit
ligand
receptor
numer
hydrophob
contact
solidifi
interact
site
similar
site
rel
hydrogen
bond
form
ligand
receptor
fig
helix
f
hydrogen
bond
made
mainchain
carbonyl
ligand
receptor
salt
bridg
found
ligand
receptor
direct
bond
present
like
contribut
initi
recognit
ligand
larg
number
nonbond
hydrophob
contact
helix
f
solidifi
interact
ligand
receptor
comparison
structur
highli
similar
il
receptor
particular
receptor
share
common
twodomain
fold
consist
two
repeat
fibronectin
type
iii
domain
link
loop
structur
differ
exist
notabl
contain
helix
loop
found
interdomain
interfac
short
helix
also
found
main
differ
presenc
helix
c
terminu
small
sheet
follow
short
helix
fibronectin
domain
locat
loop
found
presenc
anoth
short
helix
loop
found
helix
sheet
found
interdomain
region
may
contribut
lower
affin
receptor
c
rootmeansquar
displac
rmsd
align
align
align
align
also
compar
sever
cleft
found
evid
fig
specif
cleft
describ
yoon
et
al
way
much
similar
structur
support
notion
possess
uniqu
adapt
allow
bind
number
cytokin
receptor
interact
full
receptor
complex
model
sequenc
conserv
key
interact
site
high
compar
specif
model
indic
interact
occur
residu
residu
residu
correspond
residu
found
structur
align
made
make
model
full
complex
difficult
also
suggest
may
engag
compon
full
receptor
complex
primarili
associ
highaffin
interact
may
bridg
interact
also
show
high
level
similar
ifn
il
signal
molecul
share
similar
helic
bundl
fold
although
differ
detail
well
oligomer
state
surprisingli
backbon
align
base
c
coordin
found
similar
rmsd
also
structur
similar
ifn
il
known
structur
identifi
member
famili
rmsd
protein
data
bank
pdb
code
rmsd
pdb
code
rmsd
pdb
code
rmsd
pdb
code
rmsd
pdb
code
two
crystal
structur
type
iii
ifn
determin
complex
extracellular
domain
receptor
differ
crystal
pack
significantli
influenc
structur
complex
structur
highli
similar
structur
well
contain
two
domain
consist
fibronectin
type
iii
repeat
similarli
complex
defin
primarili
helic
f
sever
loop
primarili
hydrophob
natur
sever
hydrogen
bond
salt
bridg
found
two
protein
far
fewer
interact
surfac
provid
nonbond
interact
hydrophob
amino
acid
interfac
surfac
structur
suggest
bind
initi
amino
acid
capabl
make
complementari
electrostat
interact
solidifi
hydrophob
interact
ligand
receptor
structur
align
cytokin
receptor
found
ligandreceptor
complex
immedi
demonstr
bind
manner
distinct
complex
bound
similarli
interact
seen
complex
signific
nonpolar
electrostat
contact
made
helic
f
ligand
interdomain
loop
receptor
howev
align
ligand
bound
differ
portion
respect
receptor
bind
roughli
perpendicular
hing
region
fibronectin
domain
wherea
bind
interdomain
region
rotat
plane
form
fibronectin
domain
fig
similar
result
seen
align
ligandreceptor
complex
perform
shown
uniqu
bind
orient
util
could
explain
sever
way
first
like
bind
mode
evolv
receptor
ensur
recognit
upon
present
variou
cytokin
cell
surfac
second
bind
receptor
may
influenc
format
dimer
given
dimer
thought
function
form
cytokin
interact
may
requir
slightli
differ
surfac
accommod
final
differ
ligandreceptor
orient
could
influenc
latticepack
requir
alter
interact
howev
observ
mutat
greatli
disrupt
activ
locat
directli
ligandreceptor
interfac
argu
point
establish
antivir
activ
three
known
member
famili
n
n
activ
despit
seven
amino
acid
variat
fig
variat
one
visual
structur
hr
varianc
posit
number
begin
signal
peptid
interestingli
variant
posit
map
complex
none
variat
occur
interfac
local
helic
c
e
well
loop
ab
supplement
fig
variat
may
subtli
influenc
posit
helic
f
chang
interact
plausibl
variat
influenc
bind
receptor
partner
unfortun
detail
interfac
cytokin
yet
determin
although
sever
model
propos
complex
format
model
complex
interact
occur
helix
ligand
loop
receptor
along
interact
helix
specif
variat
two
occur
helix
interact
model
complex
variat
respect
like
alter
electrostat
interact
may
impact
posit
helix
slightli
disrupt
hydrophob
surfac
bind
like
variat
found
affect
interact
therebi
may
result
alter
signal
intens
durat
lead
differenti
express
antivir
gene
report
mutat
strongli
impact
antivir
activ
mani
site
mutat
presum
make
contact
receptor
mutagenesi
reveal
weak
disrupt
activ
b
increas
ec
stronger
impact
activ
increas
ec
found
mutat
wherea
strong
impact
activ
increas
ec
found
correspond
residu
follow
number
use
weak
impact
equival
strong
impact
equival
strong
impact
equival
mutat
strongli
impact
activ
posit
critic
point
interfac
residu
make
nonbond
contact
receptor
mutat
alanin
would
preserv
nonpolar
natur
amino
acid
larg
chang
hydrophob
surfac
occur
like
prevent
effici
bind
mutat
almost
complet
elimin
activ
base
structur
complex
present
highli
like
correspond
mutat
would
complet
disrupt
interact
except
mutat
almost
complet
inact
abil
mutant
still
inhibit
encephalomyocard
viru
infect
like
due
compensatori
natur
hydrophob
interfac
similar
situat
exist
around
make
nonpolar
contact
receptor
make
hydrogen
bond
receptor
well
nonbond
interact
make
hydrogen
bond
receptor
mutat
correspond
residu
greatli
decreas
antivir
activ
case
like
due
disrupt
electrostat
nonpolar
interact
equival
sever
residu
shown
affect
activ
includ
appear
interfac
like
mutat
posit
impact
posit
helic
f
bind
mutat
disrupt
proper
fold
also
directli
contact
howev
posit
immedi
adjac
helix
surfac
molecul
like
disrupt
proper
posit
helix
mutat
made
anoth
possibl
fold
maintain
interact
impact
bind
inhibit
thu
prevent
proper
signal
recent
report
glycoprotein
secret
yabalik
diseas
viru
competit
bind
simultan
inhibit
activ
type
type
iii
ifn
protein
show
low
sequenc
homolog
anoth
ifn
antagonist
produc
vaccinia
viru
knowledg
interact
secret
glycoprotein
ifn
may
provid
clue
develop
effect
antivir
drug
treat
diseas
caus
member
poxvirida
famili
use
model
ternari
complex
two
member
famili
provid
mark
walter
possibl
gain
insight
type
interact
expect
ternari
complex
receptor
align
complex
made
use
result
posit
drastic
differ
model
posit
result
make
contact
model
posit
part
heterodimer
receptor
complex
howev
align
complex
made
match
posit
make
contact
supplement
fig
furthermor
mutat
known
affect
activ
map
ternari
model
number
residu
equival
strongli
impact
activ
local
near
potenti
interfac
supplement
fig
suggest
mutat
may
impact
antiencephalomyocard
viru
activ
via
disrupt
interact
visual
variat
context
ternari
complex
interpret
variat
less
clear
none
variat
occur
interfac
residu
model
expos
solvent
supplement
fig
suggest
variat
directli
impact
bind
either
rather
indirectli
impact
bind
receptor
compon
subtl
rearrang
rearrang
may
enough
produc
differ
activ
seen
interest
note
independ
genomewid
associ
studi
identifi
sever
snp
within
region
gene
correl
spontan
clearanc
hcv
also
associ
sustain
virolog
respons
patient
chronic
hcv
undergo
pegyl
combin
therapi
genet
variant
within
gene
locu
like
affect
level
express
andor
biolog
activ
interestingli
one
snp
caus
substitut
arg
repres
natur
variat
remain
studi
whether
substitut
affect
receptor
interact
biolog
potenc
report
first
structur
complex
cellular
receptor
ligand
receptor
exhibit
topolog
similar
known
cytokin
cytokin
receptor
respect
number
subtl
variat
structur
complex
suggest
longrang
electrostat
interact
help
orient
bind
hydrophob
nonpolar
interact
solidifi
interfac
ligand
receptor
structur
offer
insight
phenotyp
mutat
regard
antivir
activ
suggest
varianc
member
influenc
differenti
antivir
activ
cytokin
howev
experiment
deriv
structur
ternari
complex
also
would
includ
receptor
molecul
need
fuller
understand
antivir
activ
type
iii
ifn
protein
product
purif
perform
previous
describ
human
encod
amino
acid
human
clone
pmt
carri
bip
drosophila
signal
peptid
upstream
ntermin
tag
protein
express
drosophila
cell
secret
directli
media
human
encod
amino
acid
express
e
coli
purchas
peprotech
purifi
use
copper
affin
chromatographi
ge
healthcar
fast
flow
chelat
sepharos
follow
sizeexclus
column
ge
healthcar
hiload
activ
purifi
verifi
demonstr
abil
induc
signal
transduc
activ
transcript
activ
use
electrophoret
mobil
shift
assay
activ
assess
abil
form
complex
complex
gener
mix
equimolar
amount
e
coli
drosophila
cell
call
bac
in
respect
incub
room
temperatur
min
complex
centrifug
subsequ
purifi
gelfiltr
column
approxim
yield
achiev
purif
final
sampl
pool
concentr
mgml
crystal
crystal
screen
experi
execut
sit
drop
use
phoenix
crystal
robot
art
robbin
instrument
crystal
screen
util
preliminari
experi
index
hampton
research
polyethylen
glycol
peg
phclear
nextal
biotechnolog
crystal
optim
easyxtaltool
plate
qiagen
use
ml
well
volum
drop
consist
protein
precipit
bac
complex
crystal
grown
peg
mm
hepe
ph
in
complex
crystal
grown
mpeg
mm
trishcl
ph
mm
trimethylamin
noxid
dehydr
crystal
complex
appear
within
day
reach
maxim
size
day
data
collect
process
perform
previous
describ
briefli
diffract
data
collect
beamlin
advanc
photon
sourc
argonn
nation
laboratori
crystal
cryoprotect
solut
compos
well
solut
supplement
glycerol
final
concentr
vv
frozen
directli
nitrogen
stream
k
diffract
data
extend
resolut
in
bac
crystal
respect
complex
crystal
orthorhomb
space
group
in
crystal
form
space
group
wherea
bac
crystal
form
space
group
data
merg
scale
integr
use
denzoscalepack
statist
list
tabl
phase
accomplish
molecular
replac
trial
util
structur
pdb
code
bind
protein
pdb
code
search
model
use
program
phaser
locat
one
copi
receptor
ligand
within
asymmetr
unit
follow
number
residu
model
base
predict
extent
signal
peptid
first
amino
acid
occur
signal
peptid
design
special
number
scheme
util
receptor
complex
model
refin
respect
data
use
phenix
final
refin
geometri
statist
list
tabl
refin
protocol
util
xyz
individu
atom
displac
paramet
occup
singl
residu
two
conform
in
solvent
filter
translationlibrationscrew
refin
follow
manual
model
inspect
manipul
coot
case
ifn
bac
complex
occup
refin
util
nlink
glycosyl
site
found
model
receptor
chain
ligand
despit
fact
in
glycosyl
three
glycosyl
site
readili
identifi
f
c
f
f
c
electron
densiti
map
contour
respect
in
crystal
wherea
two
receptor
glycosyl
site
found
bac
crystal
model
qualiti
assess
use
molprob
follow
cycl
refin
rebuild
refin
structur
deposit
pdb
access
code
in
complex
bac
complex
respect
structur
result
work
describ
well
taken
literatur
analyz
varieti
program
interfac
studi
use
pisa
pdbsum
dali
use
compar
structur
complex
known
structur
manual
inspect
structur
accomplish
use
coot
pymol
structur
figur
prepar
use
pymol
coordin
structur
factor
deposit
pdb
access
number
public
necessarili
reflect
view
polici
depart
health
human
servic
neither
mention
trade
name
commerci
product
organ
impli
endors
us
govern
